1. Home
  2. CLNE vs PBYI Comparison

CLNE vs PBYI Comparison

Compare CLNE & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clean Energy Fuels Corp.

CLNE

Clean Energy Fuels Corp.

N/A

Current Price

$1.74

Market Cap

447.1M

Sector

Utilities

ML Signal

N/A

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

N/A

Current Price

$9.28

Market Cap

467.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CLNE
PBYI
Founded
2001
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
447.1M
467.2M
IPO Year
2006
2011

Fundamental Metrics

Financial Performance
Metric
CLNE
PBYI
Price
$1.74
$9.28
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$3.32
N/A
AVG Volume (30 Days)
1.6M
267.6K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.08
Revenue
$341,599,000.00
$27,685,000.00
Revenue This Year
$1.13
N/A
Revenue Next Year
$22.65
N/A
P/E Ratio
N/A
$114.00
Revenue Growth
N/A
N/A
52 Week Low
$1.54
$4.30
52 Week High
$3.11
$9.74

Technical Indicators

Market Signals
Indicator
CLNE
PBYI
Relative Strength Index (RSI) 55.90 52.51
Support Level $1.55 $8.78
Resistance Level $1.85 $9.55
Average True Range (ATR) 0.08 0.36
MACD 0.02 -0.07
Stochastic Oscillator 91.67 37.70

Price Performance

Historical Comparison
CLNE
PBYI

About CLNE Clean Energy Fuels Corp.

Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas and liquefied natural gas for the United States (U.S.) and Canadian transportation markets. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The firm operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. It also builds, operates, and maintains natural gas fueling stations for customers.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: